Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 3;22(1):1107.
doi: 10.1186/s12889-022-13456-7.

Prevalence of Chlamydia trachomatis in the general population in Germany - a triangulation of data from two population-based health surveys and a laboratory sentinel system

Martyna Gassowski  1   2 , Christina Poethko-Müller  3 , Martin Schlaud  4 , Andrea Sailer  5 , Kerstin Dehmel  5 , Viviane Bremer  5 , Sandra Dudareva  5 , Klaus Jansen  5 ; Chlamydia trachomatis laboratory sentinel team
Collaborators, Affiliations

Prevalence of Chlamydia trachomatis in the general population in Germany - a triangulation of data from two population-based health surveys and a laboratory sentinel system

Martyna Gassowski et al. BMC Public Health. .

Abstract

Background: Chlamydia trachomatis (chlamydia) is a common, frequently asymptomatic, sexually transmitted infection. It can result in severe sequelae, such as ectopic pregnancy and infertility. In Germany, chlamydia is not notifiable. An opportunistic screening program for women < 25 years was introduced in 2008. The aim of this research was to triangulate different data sources to describe the epidemiological situation of chlamydia in Germany and to investigate whether the current target group of the chlamydia screening program aligns with these findings.

Methods: Urine specimens from participants from population-based health examination surveys of children (2014-17) and adults (2008-11) were tested for chlamydia, using nucleic acid amplification testing. These data were used to generate weighted chlamydia prevalence estimates by age group and sex. Data from a nationwide chlamydia laboratory sentinel system (2014-16) were used to calculate the positive proportion among individuals tested for chlamydia by age, sex and test reason.

Results: Using data from the population-based surveys, we found a chlamydia prevalence estimate of 2.8% (95% confidence interval (CI) 1.0-7.5%) among all 15- to 17-year-old girls and of 9.6% (95% CI 0.0-23) among those reporting to be sexually active. In adult women, we found the highest prevalence among 18- to 24-year-olds (all: 2.3%; 95% CI 1.0-5.3%; sexually active: 3.1%; 95% CI 1.3-7.0%). In adult men, we found the highest prevalence among 25- to 29-year-olds (all: 3.5%; 95% CI 1.6-7.7%; sexually active: 3.3%; 95% CI 1.3-7.8%). Data from the chlamydia laboratory sentinel showed the highest positive proportion among those opportunistically screened in 19-year-old women (6.1%; 95%- CI 5.9-6.4%), among those screened due to pregnancy in 15-year-old girls (10%; 95% CI 8.5-12%), and among those tested due to symptoms or a positive partner in 19-year-old women (10%; 95% CI 9.8-11%) and 19-year-old men (24%; 95% CI 22-26%).

Conclusions: Chlamydia seems to mainly affect adolescents and young adults in Germany, with similar overall prevalence in men and women, but with slightly different age distributions. Women at highest risk of chlamydia are covered by the current screening program but given the on-going discussions in high-income countries on cost-effectiveness and benefit-to-harm ratio of these programs, the program-aim needs reconsideration.

Keywords: Chlamydia trachomatis; Prevalence; Screening; Sexually transmitted infections.

PubMed Disclaimer

Conflict of interest statement

KJ is member of the editorial board at BMC Infectious Diseases. None of the authors declares competing interests.

Figures

Fig. 1
Fig. 1
Number of chlamydia tests by test reason, as recorded through the chlamydia laboratory sentinel system in Germany, 2014–16
Fig. 2
Fig. 2
Proportion (point estimates and 95% CI) of positive chlamydia tests by test reason, as recorded through the chlamydia laboratory sentinel system in Germany, 2014–16
See this image and copyright information in PMC

References

    1. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections . Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: WHO; 2021. p. 2021.
    1. European Centre for Disease Prevention and Control . Chlamydia infection. In: ECDC. Annual Epidemiological Report for 2016. Stockholm: ECDC; 2018.
    1. Centers for Disease Control and Prevention . Sexually Transmitted Disease Surveillance 2017. Atlanta: Department of Health and Human Services; 2018.
    1. Word Health Organization . Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. Geneva: World Health Organization; 2011.
    1. Reekie J, Donovan B, Guy R, Hocking JS, Kaldor JM, Mak DB, et al. Risk of pelvic inflammatory disease in relation to Chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study. Clin Infect Dis. 2018;66(3):437–43. doi: 10.1093/cid/cix769. - DOI - PubMed

Publication types